Indevus Gains Sanctura XR Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
The molecule’s “highly differentiated profile” will set it apart from others in the crowded urinary incontinence space, Indevus tells “The Pink Sheet” DAILY.